Multiple xenobiotics and endogenous compounds in the gastrointestinal lumen

Multiple xenobiotics and endogenous compounds in the gastrointestinal lumen refers to the diverse collection of foreign substances (xenobiotics) and natural metabolites (endogenous compounds) present within the digestive tract (DrugBank DB09278). This target is not a single protein or receptor but a broad category of molecules targeted by non-systemic binding agents to prevent their absorption or promote their excretion. Xenobiotics include ingested toxins and drugs, while endogenous compounds include bile acids, electrolytes like potassium and phosphate, and metabolic wastes (StatPearls, Activated Charcoal). Drugs such as activated charcoal, colestyramine, and patiromer interact with this target through physical adsorption, ion exchange, or chemical sequestration (NIH, Bile Acid Sequestrants). By trapping these substances in the gut, these drugs treat conditions like acute poisoning, hypercholesterolemia, and hyperkalemia (FDA, Veltassa Label). A significant therapeutic challenge is the non-specific nature of these binders, which can lead to the malabsorption of essential nutrients or other co-administered medications (Mayo Clinic, Charcoal, Activated).

Other names

Gastrointestinal lumen contentsIntestinal xenobioticsGut metabolitesIntestinal toxins and endogenous binders

Physical adsorption, ion exchange, or chemical sequestration within the gastrointestinal tract to prevent systemic absorption or promote fecal excretion.